UniProt ID | KCC2B_MOUSE | |
---|---|---|
UniProt AC | P28652 | |
Protein Name | Calcium/calmodulin-dependent protein kinase type II subunit beta | |
Gene Name | Camk2b | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 542 | |
Subcellular Localization |
Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Sarcoplasmic reticulum membrane Peripheral membrane protein Cytoplasmic side. Cell junction, synapse . |
|
Protein Description | Calcium/calmodulin-dependent protein kinase that functions autonomously after Ca(2+)/calmodulin-binding and autophosphorylation, and is involved in dendritic spine and synapse formation, neuronal plasticity and regulation of sarcoplasmic reticulum Ca(2+) transport in skeletal muscle. In neurons, plays an essential structural role in the reorganization of the actin cytoskeleton during plasticity by binding and bundling actin filaments in a kinase-independent manner. This structural function is required for correct targeting of CaMK2A, which acts downstream of NMDAR to promote dendritic spine and synapse formation and maintain synaptic plasticity which enables long-term potentiation (LTP) and hippocampus-dependent learning. In developing hippocampal neurons, promotes arborization of the dendritic tree and in mature neurons, promotes dendritic remodeling. Participates in the modulation of skeletal muscle function in response to exercise. In slow-twitch muscles, is involved in regulation of sarcoplasmic reticulum (SR) Ca(2+) transport and in fast-twitch muscle participates in the control of Ca(2+) release from the SR through phosphorylation of triadin, a ryanodine receptor-coupling factor, and phospholamban (PLN/PLB), an endogenous inhibitor of SERCA2A/ATP2A2.. | |
Protein Sequence | MATTVTCTRFTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETVECLKKFNARRKLKGAILTTMLATRNFSVGRQTTAPATMSTAASGTTMGLVEQAKSLLNKKADGVKPQTNSTKNSSAITSPKGSLPPAALEPQTTVIHNPVDGIKESSDSTNTTIEDEDAKARKQEIIKTTEQLIEAVNNGDFEAYAKICDPGLTSFEPEALGNLVEGMDFHRFYFENLLAKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWQNVHFHCSGAPVAPLQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
17 | Phosphorylation | FTDEYQLYEDIGKGA CCCCCHHHHHHCCCH | 8.95 | 20415495 | |
22 | Ubiquitination | QLYEDIGKGAFSVVR HHHHHHCCCHHHHHH | 47.61 | - | |
26 | Phosphorylation | DIGKGAFSVVRRCVK HHCCCHHHHHHHHHH | 21.11 | 18056256 | |
33 | Ubiquitination | SVVRRCVKLCTGHEY HHHHHHHHHHCCCHH | 41.28 | - | |
35 | S-nitrosylation | VRRCVKLCTGHEYAA HHHHHHHHCCCHHHH | 3.38 | 24895380 | |
40 | Phosphorylation | KLCTGHEYAAKIINT HHHCCCHHHHHHHHC | 13.24 | 29899451 | |
43 | Ubiquitination | TGHEYAAKIINTKKL CCCHHHHHHHHCCCC | 35.63 | - | |
48 | Acetylation | AAKIINTKKLSARDH HHHHHHCCCCCHHHH | 47.42 | 7848607 | |
48 | Ubiquitination | AAKIINTKKLSARDH HHHHHHCCCCCHHHH | 47.42 | - | |
49 | Ubiquitination | AKIINTKKLSARDHQ HHHHHCCCCCHHHHH | 45.71 | - | |
69 | Ubiquitination | ARICRLLKHSNIVRL HHHHHHHHHCCEEEE | 49.97 | - | |
79 | Phosphorylation | NIVRLHDSISEEGFH CEEEECCCCCCCCCE | 19.78 | - | |
138 | Ubiquitination | GVVHRDLKPENLLLA CCCCCCCCHHHHHHH | 55.35 | - | |
146 | Phosphorylation | PENLLLASKCKGAAV HHHHHHHHCCCCCCE | 38.26 | 22817900 | |
147 | Ubiquitination | ENLLLASKCKGAAVK HHHHHHHCCCCCCEE | 34.07 | - | |
182 | Phosphorylation | AGTPGYLSPEVLRKE CCCCCCCCHHHHHHH | 15.55 | 23737553 | |
227 | Ubiquitination | HKLYQQIKAGAYDFP HHHHHHHHHCCCCCC | 36.11 | - | |
231 | Phosphorylation | QQIKAGAYDFPSPEW HHHHHCCCCCCCCCH | 19.73 | 24925903 | |
235 | Phosphorylation | AGAYDFPSPEWDTVT HCCCCCCCCCHHCCC | 35.13 | 24925903 | |
240 | Phosphorylation | FPSPEWDTVTPEAKN CCCCCHHCCCHHHHH | 27.61 | 24925903 | |
242 | Phosphorylation | SPEWDTVTPEAKNLI CCCHHCCCHHHHHHH | 19.94 | 24925903 | |
246 | Ubiquitination | DTVTPEAKNLINQML HCCCHHHHHHHHHHH | 51.10 | - | |
254 | Phosphorylation | NLINQMLTINPAKRI HHHHHHHCCCHHHCC | 17.23 | 25521595 | |
259 | Ubiquitination | MLTINPAKRITAHEA HHCCCHHHCCCHHHH | 45.66 | - | |
268 | Ubiquitination | ITAHEALKHPWVCQR CCHHHHHCCCCHHCH | 55.45 | - | |
276 | Phosphorylation | HPWVCQRSTVASMMH CCCHHCHHHHHHHHH | 11.01 | 25521595 | |
277 | Phosphorylation | PWVCQRSTVASMMHR CCHHCHHHHHHHHHH | 23.45 | 25521595 | |
280 | Phosphorylation | CQRSTVASMMHRQET HCHHHHHHHHHHHHH | 16.59 | 25521595 | |
287 | Phosphorylation | SMMHRQETVECLKKF HHHHHHHHHHHHHHH | 17.17 | 25521595 | |
290 | S-nitrosylation | HRQETVECLKKFNAR HHHHHHHHHHHHCHH | 6.16 | 24895380 | |
299 | Methylation | KKFNARRKLKGAILT HHHCHHHHHHHHHHH | 49.34 | - | |
301 | Ubiquitination | FNARRKLKGAILTTM HCHHHHHHHHHHHHH | 49.70 | - | |
301 | Methylation | FNARRKLKGAILTTM HCHHHHHHHHHHHHH | 49.70 | - | |
306 | Phosphorylation | KLKGAILTTMLATRN HHHHHHHHHHHHCCC | 12.21 | 20415495 | |
307 | Phosphorylation | LKGAILTTMLATRNF HHHHHHHHHHHCCCC | 13.52 | 20415495 | |
307 | O-linked_Glycosylation | LKGAILTTMLATRNF HHHHHHHHHHHCCCC | 13.52 | 4041595 | |
311 | Phosphorylation | ILTTMLATRNFSVGR HHHHHHHCCCCCCCC | 23.37 | 20415495 | |
315 | Phosphorylation | MLATRNFSVGRQTTA HHHCCCCCCCCCCCC | 27.49 | 28542873 | |
320 | Phosphorylation | NFSVGRQTTAPATMS CCCCCCCCCCCCCCC | 24.46 | 29899451 | |
321 | Phosphorylation | FSVGRQTTAPATMST CCCCCCCCCCCCCCC | 23.47 | 18056256 | |
325 | Phosphorylation | RQTTAPATMSTAASG CCCCCCCCCCCCCCC | 15.59 | 25521595 | |
325 | O-linked_Glycosylation | RQTTAPATMSTAASG CCCCCCCCCCCCCCC | 15.59 | 100712363 | |
327 | Phosphorylation | TTAPATMSTAASGTT CCCCCCCCCCCCCCC | 15.56 | 20415495 | |
327 | O-linked_Glycosylation | TTAPATMSTAASGTT CCCCCCCCCCCCCCC | 15.56 | 100712369 | |
328 | O-linked_Glycosylation | TAPATMSTAASGTTM CCCCCCCCCCCCCCH | 18.54 | 68716875 | |
328 | Phosphorylation | TAPATMSTAASGTTM CCCCCCCCCCCCCCH | 18.54 | 25521595 | |
331 | Phosphorylation | ATMSTAASGTTMGLV CCCCCCCCCCCHHHH | 33.92 | 25521595 | |
333 | Phosphorylation | MSTAASGTTMGLVEQ CCCCCCCCCHHHHHH | 15.89 | 19060867 | |
334 | Phosphorylation | STAASGTTMGLVEQA CCCCCCCCHHHHHHH | 16.87 | 21183079 | |
343 | Phosphorylation | GLVEQAKSLLNKKAD HHHHHHHHHHHHCCC | 40.90 | 22322096 | |
347 | Acetylation | QAKSLLNKKADGVKP HHHHHHHHCCCCCCC | 49.67 | 7610711 | |
356 | Phosphorylation | ADGVKPQTNSTKNSS CCCCCCCCCCCCCCC | 39.40 | 20415495 | |
358 | Phosphorylation | GVKPQTNSTKNSSAI CCCCCCCCCCCCCCC | 44.11 | 25521595 | |
359 | Phosphorylation | VKPQTNSTKNSSAIT CCCCCCCCCCCCCCC | 35.99 | 20415495 | |
362 | Phosphorylation | QTNSTKNSSAITSPK CCCCCCCCCCCCCCC | 23.78 | 24925903 | |
363 | Phosphorylation | TNSTKNSSAITSPKG CCCCCCCCCCCCCCC | 32.84 | 25521595 | |
366 | Phosphorylation | TKNSSAITSPKGSLP CCCCCCCCCCCCCCC | 38.40 | 22324799 | |
367 | Phosphorylation | KNSSAITSPKGSLPP CCCCCCCCCCCCCCH | 20.64 | 25521595 | |
371 | Phosphorylation | AITSPKGSLPPAALE CCCCCCCCCCHHHCC | 43.77 | 22324799 | |
381 | Phosphorylation | PAALEPQTTVIHNPV HHHCCCCCEEEECCC | 33.47 | 25521595 | |
382 | Phosphorylation | AALEPQTTVIHNPVD HHCCCCCEEEECCCC | 16.53 | 25521595 | |
394 | Phosphorylation | PVDGIKESSDSTNTT CCCCCCCCCCCCCCC | 34.15 | 25521595 | |
395 | Phosphorylation | VDGIKESSDSTNTTI CCCCCCCCCCCCCCC | 36.35 | 25521595 | |
397 | Phosphorylation | GIKESSDSTNTTIED CCCCCCCCCCCCCCH | 26.04 | 25521595 | |
398 | Phosphorylation | IKESSDSTNTTIEDE CCCCCCCCCCCCCHH | 41.39 | 25521595 | |
400 | Phosphorylation | ESSDSTNTTIEDEDA CCCCCCCCCCCHHHH | 29.28 | 25521595 | |
401 | Phosphorylation | SSDSTNTTIEDEDAK CCCCCCCCCCHHHHH | 25.16 | 25521595 | |
469 | Ubiquitination | YFENLLAKNSKPIHT HHHHHHHCCCCCCEE | 62.82 | - | |
510 | Phosphorylation | DGQGRPRTSQSEETR CCCCCCCCCCCCCCE | 33.53 | 22807455 | |
533 | S-palmitoylation | WQNVHFHCSGAPVAP CEEEEEEECCCCCCC | 3.82 | 28680068 | |
533 | S-nitrosylation | WQNVHFHCSGAPVAP CEEEEEEECCCCCCC | 3.82 | 24895380 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KCC2B_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of KCC2B_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Qualitative and quantitative analyses of protein phosphorylation innaive and stimulated mouse synaptosomal preparations."; Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F.,Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D.,Gerrits B., Panse C., Schlapbach R., Mansuy I.M.; Mol. Cell. Proteomics 6:283-293(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-367; THR-287 ANDSER-397, AND MASS SPECTROMETRY. | |
"Proteomic analysis of in vivo phosphorylated synaptic proteins."; Collins M.O., Yu L., Coba M.P., Husi H., Campuzano I.,Blackstock W.P., Choudhary J.S., Grant S.G.; J. Biol. Chem. 280:5972-5982(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315, AND MASSSPECTROMETRY. | |
"Comprehensive identification of phosphorylation sites in postsynapticdensity preparations."; Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R.,Burlingame A.L.; Mol. Cell. Proteomics 5:914-922(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-287, AND MASSSPECTROMETRY. | |
"Large-scale identification and evolution indexing of tyrosinephosphorylation sites from murine brain."; Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.; J. Proteome Res. 7:311-318(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-17, AND MASSSPECTROMETRY. |